MAPT and Alzheimer disease: Unlike pharmaceutical treatments that primarily offer symptomatic relief, TCIM encompasses holistic approaches that target multiple pathophysiological pathways involved in AD, including tau pathology, oxidative stress, mitochondrial dysfunction, and neuroinflammation.